JAMA Pediatrics
(Redirected from American Journal of Diseases of Children)
JAMA Pediatrics: A Leading Journal in Pediatric Medicine[edit | edit source]
JAMA Pediatrics is a renowned peer-reviewed medical journal that focuses on the field of pediatric medicine. It is published by the American Medical Association (AMA) and covers a wide range of topics related to child health and development. This article aims to provide an overview of JAMA Pediatrics, its significance in the medical community, and the valuable resources it offers to healthcare professionals and researchers.
History[edit | edit source]
JAMA Pediatrics, formerly known as the American Journal of Diseases of Children, was first published in 1911. It has since evolved into a leading publication in the field of pediatrics, providing cutting-edge research, clinical studies, and expert opinions. The journal underwent a name change in 1993 to better reflect its focus on pediatrics.
Scope and Coverage[edit | edit source]
JAMA Pediatrics covers a broad spectrum of topics related to child health, including but not limited to:
- Pediatric diseases and disorders
- Child development and behavior
- Neonatology
- Adolescent medicine
- Pediatric surgery
- Pediatric pharmacology
- Pediatric genetics
- Pediatric infectious diseases
The journal publishes original research articles, systematic reviews, clinical trials, case reports, and editorials. It also features commentaries and perspectives on current issues in pediatric medicine.
Peer Review Process[edit | edit source]
JAMA Pediatrics follows a rigorous peer review process to ensure the quality and validity of the published articles. All submissions undergo a thorough evaluation by experts in the respective fields. The peer review process helps maintain the journal's reputation for publishing high-quality research and upholding scientific integrity.
Impact Factor and Ranking[edit | edit source]
JAMA Pediatrics has consistently maintained a high impact factor, which is a measure of the average number of citations received by articles published in the journal. The impact factor reflects the influence and importance of the journal within the scientific community. As of 2021, JAMA Pediatrics has an impact factor of X.XX, indicating its significant contribution to the field of pediatric medicine.
In terms of ranking, JAMA Pediatrics is among the top journals in the field of pediatrics. It is highly regarded by healthcare professionals, researchers, and academicians worldwide.
Online Resources[edit | edit source]
JAMA Pediatrics provides a wealth of online resources that are easily accessible to healthcare professionals, researchers, and the general public. These resources include:
- Full-text articles: The journal offers free access to selected articles, allowing readers to stay updated with the latest research in pediatric medicine.
- Podcasts: JAMA Pediatrics produces podcasts that discuss key findings from published articles, interviews with experts, and emerging trends in pediatric medicine.
- Clinical Guidelines: The journal publishes evidence-based clinical guidelines to assist healthcare professionals in making informed decisions regarding the diagnosis, treatment, and management of pediatric conditions.
- Continuing Medical Education (CME): JAMA Pediatrics offers CME activities, allowing healthcare professionals to earn credits while staying updated with the latest advancements in pediatric medicine.
Conclusion[edit | edit source]
JAMA Pediatrics is a highly respected medical journal that plays a crucial role in advancing the field of pediatric medicine. Its comprehensive coverage, rigorous peer review process, and high impact factor make it a valuable resource for healthcare professionals, researchers, and anyone interested in child health. By providing access to cutting-edge research and expert opinions, JAMA Pediatrics continues to contribute significantly to the improvement of pediatric healthcare worldwide.
JAMA Pediatrics Resources | |
---|---|
|
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD